In the Media

Amy Dockser Marcus of The Wall Street Journal writes about the growing interest in using CRISPR as a diagnostic tool, which led to a collaboration between MIT Professors James Collins and Feng Zhang. The result is Sherlock, a diagnostic platform that can identify viruses “based on extremely low amounts of RNA in blood and urine samples,” explains Dockser Marcus.